ATF3 transcription factor and its emerging roles in immunity and cancer.
Activating transcription factor 3 (ATF3) is a member of the ATF/cyclic AMP response element-binding (ATF/CREB) family of transcription factors. It is an adaptive-response gene that participates in cellular processes to adapt to extra- and/or intracellular changes, where it transduces signals from various receptors to activate or repress gene expression. Advances made in understanding the immunobiology of Toll-like receptors have recently generated new momentum for the study of ATF3 in immunity. Moreover, the role of ATF3 in the regulation of the cell cycle and apoptosis has important implications for understanding susceptibility to and progression of several cancers.
Thompson
Matthew R
MR
Monash Institute of Medical Research, Monash University, Melbourne, Australia.
Xu
Dakang
D
Williams
Bryan R G
BR
D051700:Activating Transcription Factor 3 / Q000235:genetics* / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007113:Immunity, Innate; D009369:Neoplasms / Q000235:genetics / Q000276:immunology*
D051700:Activating Transcription Factor 3
Oncogene. 2005 Mar 3;24(10):1774-87
15674352
Cancer Res. 2006 Dec 15;66(24):11983-90
17178897
Anticancer Res. 1999 May-Jun;19(3A):1779-83
10470115
J Immunol. 2007 Sep 15;179(6):3622-30
17785797
Diabetes. 2008 Mar;57(3):635-44
18057093
Mol Cancer Ther. 2005 Feb;4(2):233-41
15713895
Cancer Res. 2004 Aug 15;64(16):5850-60
15313929
Cancer Res. 2006 Feb 15;66(4):2376-84
16489044
Jpn J Cancer Res. 2000 Aug;91(8):833-6
10965025
J Biol Chem. 2008 Oct 31;283(44):29795-801
18755691
J Biol Chem. 2006 Apr 14;281(15):10473-81
16469745
J Biol Chem. 1988 Dec 5;263(34):18466-72
2848037
Exp Cell Res. 2001 Jul 15;267(2):193-204
11426938
BMC Cancer. 2008 Sep 22;8:268
18808719
Nature. 1987 Jul 9-15;328(6126):175-8
2885756
Oncogene. 2008 Apr 3;27(15):2118-27
17952119
Nature. 2006 May 11;441(7090):173-8
16688168
Nat Med. 2003 Jan;9(1):33-9
12496961
J Urol. 2006 Apr;175(4):1517-22
16516039
Blood. 2006 Mar 15;107(6):2536-9
16263788
J Exp Med. 2008 Sep 29;205(10):2349-57
18794337
Genes Dev. 1998 Apr 1;12(7):982-95
9531536
J Biol Chem. 1995 May 19;270(20):12210-8
7744871
Mol Cancer Ther. 2005 May;4(5):693-703
15897233
Nat Immunol. 2009 Apr;10(4):437-43
19270711
Mol Endocrinol. 1994 Jan;8(1):59-68
8152431
Proc Natl Acad Sci U S A. 1991 May 1;88(9):3720-4
1827203
Gene Expr. 1999;7(4-6):321-35
10440233
Mol Carcinog. 2007 Jun;46(6):476-87
17295236
Nature. 1998 Feb 26;391(6670):900-4
9495343
Mol Cell Biol. 1997 Nov;17(11):6700-7
9343434
Adv Drug Deliv Rev. 2000 Nov 15;44(2-3):119-34
11072110
Oncogene. 2006 Mar 13;25(11):1620-8
16550162
Biochem J. 1999 Apr 1;339 ( Pt 1):135-41
10085237
Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):652-6
18178624
Cell Cycle. 2007 Mar 15;6(6):705-13
17374994
Science. 2007 Jul 6;317(5834):124-7
17615359
Mol Cell Biol. 2004 Jul;24(13):5721-32
15199129
Springer Semin Immunopathol. 2000;22(1-2):125-32
10944807
Carcinogenesis. 2004 Nov;25(11):2155-64
15271854
Mol Immunol. 2007 Mar;44(7):1598-605
16982098
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2544-9
18268321
J Biol Chem. 1994 Jun 3;269(22):15819-26
7515060
Mol Cell Biol. 1992 Oct;12(10):4654-65
1406655
Differentiation. 2006 Dec;74(9-10):481-7
17177845
Cell Death Differ. 2006 May;13(5):816-25
16410796
Proc Natl Acad Sci U S A. 1991 May 1;88(9):3511-5
1902565
Genes Dev. 1989 Dec;3(12B):2083-90
2516827
J Biol Chem. 2003 Jul 11;278(28):25790-801
12734198
Mol Cell. 2003 Apr;11(4):915-26
12718878